Eli Lilly & Co. (LLY) Tops Q4 EPS by 21c, Updates FY Guidance
Tweet
Share
E-mail
Get Alerts LLY Hot Sheet
Price: $1,107.08 +0.45%
Revenue Growth %: +31.7%
Financial Fact:
Cost of sales: 1.4B
Today's EPS Names:
CRWS, MEI, PODC, More
Revenue Growth %: +31.7%
Financial Fact:
Cost of sales: 1.4B
Today's EPS Names:
CRWS, MEI, PODC, More
Join SI Premium – FREE
Eli Lilly & Co. (NYSE: LLY) reported Q4 EPS of $1.73, $0.21 better than the analyst estimate of $1.52. Revenue for the quarter came in at $6.11 billion versus the consensus estimate of $5.91 billion.
GUIDANCE:
Eli Lilly & Co. sees FY2020 EPS of $6.70-$6.80, versus the consensus of $6.76. Eli Lilly & Co. sees FY2020 revenue of $23.7-24.2 billion, versus the consensus of $23.82 billion.
For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- JPMorgan Downgrades Tata Technologies (TATATECH:IN) to Underweight
- Stifel Canada Starts BlackBerry (BB) at Buy
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
